Yahoo Web Search

  1. Ads
    related to Amgen Inc
  1. Is a Beat in Store for Amarin (AMRN) This Earnings Season?

    Zacks via Yahoo FinanceOct 29 14:25 PM

    We expect Amarin Corporation PLC AMRN to beat expectations when it reports third-quarter 2019 results on Nov 7, before market open. In the last reported quarter, the company delivered a positive ...

  2. NASDAQ: SGEN) Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) (reacted to a positive clinical readout) (Biotech stocks that hit 52-week lows Oct. 28. Agile Therapeutics Inc (NASDAQ: AGRX ...

  3. Amgen third-quarter revenue falls 3%, biosimilar sales rise

    Reuters via Yahoo FinanceOct 29 20:07 PM

    By Deena Beasley Oct 29 (Reuters) - Amgen Inc on Tuesday said competition for older off-patent drugs sent third-quarter revenue down 3%, but share repurchases and biosimilar sales ...

  4. Biotech ETFs in Focus on Impressive Q3 Earnings Results

    Zacks via Yahoo FinanceNov 04 22:05 PM

    Total revenues of $5.74 billion in the quarter outpaced the Zacks Consensus Estimate of $5.63 billion. However, total revenues declined 3% year over year. The company slightly raised its previously ...

  5. 5 Cheap Stocks Near 52-Week Highs

    GuruFocus.com via Yahoo FinanceOct 28 21:05 PM

    Citigroup Inc. (NYSE:C) is trading with a price-earnings ratio of 9.59, which is higher than 69% of companies in the Banks industry. Its earnings per share have grown 7.30% over the past ...

  6. Vertex Pharmaceuticals Incorporated VRTX is scheduled to report third-quarter 2019 results on Oct 30, after the market closes. Vertex boasts an excellent earnings surprise history, surpassing ...

  7. Value Biotech ETFs & Stocks to Buy Now

    Zacks via Yahoo FinanceNov 04 18:00 PM

    The winning momentum for M&A started from December 2018, when Glaxo GSK offered to acquire TESARO for almost $5.1 billion. With this deal, Glaxo's objective was to get access to TESARO's PARP ...

  8. Celgene Corporation CELG reported adjusted earnings of $2.99 per share in third-quarter 2019, which beat the Zacks Consensus Estimate of $2.73 and increased from $2.29 a year ago. Moreover, ...

  9. Radius Health, Inc. RDUS reported encouraging results for the third quarter of 2019, wherein loss was narrower than expected and sales surpassed estimates. The company incurred a loss ...

  10. Amgen: 3Q Earnings Snapshot

    Associated Press via Yahoo FinanceOct 29 20:10 PM

    On a per-share basis, the Thousand Oaks, California-based company said it had net income of $3.27. Earnings, adjusted for non-recurring costs, came to $3.66 per share. The results topped Wall Street expectations.

  1. Ads
    related to Amgen Inc